Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Loss of Consciousness in General Anesthesia
NCT04901871Phase 3Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- May 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam in general anesthesia, sponsored by Gangnam Severance Hospital. Started May 2021; status: completed.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT04901871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04901871.